Tamsulosin Monotherapy versus Combination Therapy with Antibiotics or Anti-Inflammatory Agents in the Treatment of Chronic Pelvic Pain Syndrome
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Chronic pelvic pain syndrome (CPPS) is treated by use of various protocols. We compared tamsulosin monotherapy with tamsulosin in combination with antibiotics or anti-inflammatory agents and evaluated the efficacy of these treatments in patients with CPPS. Methods: Patients (n=107) who were younger than 55 years and diagnosed with CPPS were randomly assigned to treatment with tamsulosin at 0.2 mg (group A), tamsulosin at 0.2 mg plus anti-inflammatory drugs (group B) or tamsulosin at 0.2 mg plus antibiotics (group C) daily. We applied the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) and the International Prostate Symptom Score (IPSS) to evaluate 100 patients who were treated for 12 weeks (7 withdrew). Scores of the three groups were compared by analysis of variance and we also evaluated subscores, which included pain, voiding and quality of life (QoL). Results: All three groups showed statistically significant decreases in NIH-CPSI score, IPSS and subscore scores (P<0.05). There were no statistically significant differences between the groups except for the QoL domain of the IPSS (group A vs. C; P<0.01). Conclusions: Tamsulosin monotherapy for 12 weeks was effective for treating patients with CPPS, compared with combination therapy with antibiotics or anti-inflammatory drugs.
Abstract
Purpose: Chronic pelvic pain syndrome (CPPS) is treated by use of various protocols. We compared tamsulosin monotherapy with tamsulosin in combination with antibiotics or anti-inflammatory agents and evaluated the efficacy of these treatments in patients with CPPS. Methods: Patients (n=107) who were younger than 55 years and diagnosed with CPPS were randomly assigned to treatment with tamsulosin at 0.2 mg (group A), tamsulosin at 0.2 mg plus anti-inflammatory drugs (group B) or tamsulosin at 0.2 mg plus antibiotics (group C) daily. We applied the National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) and the International Prostate Symptom Score (IPSS) to evaluate 100 patients who were treated for 12 weeks (7 withdrew). Scores of the three groups were compared by analysis of variance and we also evaluated subscores, which included pain, voiding and quality of life (QoL). Results: All three groups showed statistically significant decreases in NIH-CPSI score, IPSS and subscore scores (P<0.05). There were no statistically significant differences between the groups except for the QoL domain of the IPSS (group A vs. C; P<0.01). Conclusions: Tamsulosin monotherapy for 12 weeks was effective for treating patients with CPPS, compared with combination therapy with antibiotics or anti-inflammatory drugs.
참고문헌 (29)
- Collins MM, "How common is prostatitis? A national survey of physician visits", J Urol, 159, pp.1224~1228 (1998)
- Yoo YN, "Prostatitis", Korean J Urol, 35, pp.575~585 (1994)
- Wenninger K, "Sickness impact of chronic nonbacterial prostatitis and its corre\-lates", J Urol, 155, pp.965~968 (1996)
- Nickel JC, "Research guidelines for chronic prostatitis: consensus report from the first National Insti\-tutes of Health International Prostatitis Collaborative Network", Urology, 54, pp.229~233 (1999)
- Nickel JC, "Prostatitis: evolving management strategies", Urol Clin North Am, 26, pp.737~751 (1999)
- Krieger JN, "Chronic pelvic pains represent the most prominent urogenital symptoms of “chron\-ic prostatitis”", Urology, 48, pp.715~721 (1996)
- Shoskes DA, "Long-term results of multimodal therapy for chronic prostatitis", chronic pelvic pain syndrome, 2003, pp.169, 1406~1410
- 조인래, "전립선염의 현재와 미래", Korean Journal of Urology, 49(6), pp.475~489 (2008), 대한비뇨기과학회
- Osborn DE, "Prostatodynia: physiological characteristics and rational management with muscle relaxants", Br J Urol, 53, pp.621~623 (1981)
- Lacquaniti S, "Terazosine and tamsulosin in non bacterial prostatitis: a randomized placebo-controlled study", Arch Ital Urol Androl, 71, pp.283~285 (1999)
- de la Rosette JJ, "Research in rostatitis syndromes? the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities", Eur Urol, 22, pp.222~227 (1992)
- Neal DE Jr, "Use of terazosin in prostatodynia and validation of a symptom score questionnaire", Urology, 43, pp.460~465 (1994)
- Cheah PY, "Terazosin therapy for chronic prostatitis", chronic pelvic pain syndrome: a randomized, placebo controlled trial, 2003, pp.169, 592~596
- Nickel JC, "Treatment of chronic prostatitis", chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial, 2004, pp.171, 1594~1597
- Mehik A, "Alfuzosin treatment for chronic prostatitis", chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study, 2003, pp.62, 425~429
- Zermann D, "Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain", Eur Urol, 38, pp.393~399 (2000)
- Nickel JC, "A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)", BJU Int, 93, pp.991~994 (2004)
- Persson BE, "Ameliorative effect of allopurinol on nonbacterial prostatitis: a parallel double-blind controlled study", J Urol, 155, pp.961~964 (1996)
- Nickel JC, "Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study", J Urol, 173, pp.1252~1255 (2005)
- Shim BS, "Complementary and alternative therapy for chronic prostatitis", chronic pelvic pain syndrome, 2007, pp.2, 143~150
- 양상국, "난치성 만성골반통증후군 환자에서 바이오피드백 및 기능성전기자극의 치료효과", Korean Journal of Urology, 44(12), pp.1220~1224 (2003), 대한비뇨기과학회
- 조인래, "전립선염의 진단과 치료", The World Journal of Men's Health, 23(1), pp.1~11 (2005), 대한남성과학회
- Yavaaou I, "Role of ejaculation in the treatment of chronic non-bacterial prostatitis", Int J Urol, 6, pp.130~134 (1996)
- Blacklock NJ, "Anatomical factors in prostatitis", Br J Urol, 46, pp.47~54 (1974)
- 김태형, "만성전립선염에서 다중 중합효소연쇄반응을 이용한 잠복 미생물의 검출", Korean Journal of Urology, 48(3), pp.304~309 (2007), 대한비뇨기과학회
- Nickel JC, "Canadian Prostatitis Research Group. Predictors of patient response to antibiotic therapy for the chronic prostatitis", chronic pelvic pain syndrome: a prospective multicenter clinical trial, 2001, pp.165, 1539~1544
- 윤철웅, "염증성 만성골반통증후군 환자에서 항생제 단독요법과 항생제 및 알파차단제 병합요법의 치료효과 비교", Korean Journal of Urology, 49(1), pp.72~76 (2008), 대한비뇨기과학회
- Nickel JC, "A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis", J Urol, 169, pp.1401~1405 (2003)
- Minnery CH, "Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and Ibuprofen", J Urol, 174, pp.375~379 (2005)